期刊文献+

ERCP术后并发胰腺炎的预防 被引量:5

在线阅读 下载PDF
导出
摘要 胰胆疾病是消化系统的常见病,内镜下逆行胰胆管造影术(ERCP)是胰胆疾病诊治的重要手段,临床应用日趋广泛。ERCP最严重的并发症为ERCP术后胰腺炎(PEP)[1],按Cotton标准,ERCP后出现持续腹痛且血清淀粉酶高于正常上限3倍持续24h以上者,诊断为PEP,其发生率约1%~9%,而在高危患者可达10%~30%,其中约有1%发展为重症急性胰腺炎,甚至引起患者死亡。这将增加患者的住院时间和加重患者精神、心理和经济负担,增加医疗资源的耗费。因此,有效的预防PEP对提高ERCP的诊疗水平及安全性有重要的意义。现将PEP发生的危险因素及预防做一综述。
出处 《广西医科大学学报》 CAS 2012年第2期314-316,共3页 Journal of Guangxi Medical University
基金 南宁市科学研究与技术开发计划基金资助项目(No.200501083C)
  • 相关文献

参考文献25

  • 1Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis[J]. Endoscopy, 2010,42:503-515.
  • 2Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and theirmanagement ~ an attempt at consensus[J]. Gastrointest Endoscpy,1991, 37 : 383-393.
  • 3Vandervoort J,Soetikno RM,Tham TC, et al. Risk factors for complications after performance of ERCP[J]. Gastrointest Endosc,2002,56(5) : 652-656.
  • 4Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study [J]. AmJ Gastroenterol ,2009,104(1): 31-40.
  • 5Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP~ a prospective multi- center study[J]. Am J Gastroenterol, 2001,96 (2) : 417-423.
  • 6Kapral C, Duller C, Wewalka F, et al. Case volume and outcome of endoscopic retrograde cholangiopancre- atography~ results of a nationwide austrian benchmarking project[J]. Endoscopy,2008,40 : 625-630.
  • 7Rudin D, Kiss A,Wetz R V, et al. Somatostatin and gabexate for post-endoscopic retrograde cholangiopan- creatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials [J]. Journal of Gastroenterology and Hepatology, 2007, 22 (7) : 977- 983.
  • 8Andriulli A, Leandro G, Federici T,et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-anal- ysis[J]. Gastrointestinal Endoscopy, 2007,65 (4) : 624- 632.
  • 9Testoni PA, Bagnolo F, Andriulli A,et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial[J]. Alimentary Pharmacology Therapeutics, 2001,15(7):965-972.
  • 10Bai Y,Gao J, Zou DW,et al. Prophylactic octreotide ad- ministration does not prevent post-endoscopic retro- grade cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials [J]. Pancreas, 2008, 37(3): 241-246.

二级参考文献20

  • 1张优萍,李建阳,王海珍,张美婷.导丝替代造影剂降低ERCP术后胰腺炎的临床效果[J].浙江实用医学,2005,10(1):13-14. 被引量:7
  • 2Lella F,Bagnolo F,Colombo E,et al.A simple way of avoiding post-ERCP pancreatitis.Gastrointest Endosc,2004,59:830-834.
  • 3Vandervoort J,Soetikno RM,Tham TC,et al.Risk factors for complications after performance of ERCP.Gastrointest Endosc,2002,56:652-656.
  • 4Scott-Conner CH 著,李际辉译.美国胃肠内镜外科医师学会手册,北京:人民军医出版社,2004:436-467.
  • 5Cotton PB,Lehman G,Vennes J,et al.Endoscopic sphincterotomy complications and their management:an attempt at consensus.Gastrointest Endosc,1991,37:383-393.
  • 6Katsinelos P,Kountouras J,Chatzis J,et al.High-dose allopurinol for prevention of post-ERCP pancreatitis:a prospective randomized double-blind controlled trial.Gastrointest Endosc,2005,61:407-415.
  • 7McCune WS,Shorb PE,Moscovitz H.Endoscopic cannulation of the ampulla of Vater:a preliminary report.Ann Surg,1968,167:752-756.
  • 8Sherman S,Lehman GA.ERCP and endoscopic sphincterotomy-induced pancreatitis.Pancreas,1991,6:350-367.
  • 9Freeman M,Guda N.Prevention of post-ERCP pancreatitis:a comprehensive review.Gastrointest Endosc,2004,59:845-864.
  • 10Sherman S,Lehman G,Freeman ML,et al.Risk factors for post-ERCP pancreatitis:a prospe-ctive multicenter study.Am J Gastroenterol,1997,92:1639.

共引文献53

同被引文献51

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部